Tissue factor pathway inhibitor: proposed heparin recognition region

Area of Science:

• Biochemistry
• Pharmacology
• Hematology

Background:

• Heparins and low-molecular-weight heparins are known to release tissue factor pathway inhibitor (TFPI) into circulation.
• Protamine administration effectively reverses TFPI plasma levels to baseline.
• Low-molecular-weight dermatan sulfate exhibits minimal TFPI release, suggesting specificity in the interaction.

Purpose of the Study:

• To investigate the specific mechanism of TFPI release induced by acidic glycosaminoglycans.
• To identify and characterize the heparin-binding region within TFPI.
• To compare the structural similarities between TFPI and other heparin-binding proteins like antithrombin III.

Main Methods:

• Analysis of TFPI plasma levels following administration of various glycosaminoglycans.
• Identification of a putative heparin-binding site through sequence analysis of TFPI.
• Structural comparison using helical wheel diagrams of TFPI and antithrombin III.

Main Results:

• A specific heparin-binding region, characterized by a basic amino acid cluster (256-lysine to 261-lysine), was identified at the C-terminal end of TFPI.
• This region shows structural similarity to the heparin recognition site in antithrombin III.
• The binding interaction between TFPI and glycosaminoglycans is proposed to occur in a linear fashion.

Conclusions:

• TFPI is specifically released by acidic glycosaminoglycans, likely through binding to a C-terminal heparin recognition region.
• This interaction mechanism is conserved among heparin-binding proteins, as evidenced by comparisons with antithrombin III.
• Further research is warranted to elucidate the precise molecular interactions involved.